title: Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report.
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Yamamura
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Otsuka
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Yo
authors.initials: Y
authors.lastname: Kaku
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Seidel
authors.affiliation: Department of Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Motoo
authors.initials: M
authors.lastname: Nomura
authors.affiliation: Department of Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Nagai
authors.affiliation: Department of Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Shigemi
authors.initials: S
authors.lastname: Matsumoto
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.|Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.|PRESTO, Japan Science and Technology Agency, Saitama, Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D001706:Biopsy; D046169:Dermoscopy; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology*; D000077594:Nivolumab / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D000096142:Cutaneous Malignant Melanoma
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000077594:Nivolumab